Pharmachem Private Limited Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Pharmachem Private Limited Pharmaceutical Import Records from India — 4 Products, $282.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmachem Private Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $282.4K Trade | TransData Nexus

Pharmachem Private Limited

Pharmaceutical Importer · Nepal · Advanced Oncology Focus · $282.4K Total Trade · DGFT Verified

Pharmachem Private Limited is a pharmaceutical importer based in Nepal with a total trade value of $282.4K across 4 products in 4 therapeutic categories. Based on 46 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmachem Private Limited sources from 14 verified Indian suppliers, with Abbott India Limited accounting for 30.9% of imports.

Pharmachem Private Limited — Import Portfolio & Supplier Network

Pharmachem Private Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmachem Private Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Abbott India Limited	$11.6M	1,011	30.9%
Usv Private Limited	$9.9M	1,027	26.2%
Glenmark Pharmaceuticals Limited	$5.4M

What Formulations Does Pharmachem Private Limited Import?

Formulation	Value	Ships
Thyronorm 25 MCG 120s ( h l medicine )	$389.3K	31
Influvac tetra 1x0.5 ML nh 2022-23	$300.0K	6
Thyronorm 50 MCG 120s pill dose	$295.0K	35
Thyronorm 25 MCG 120s pill dose	$241.3K	24
Ryzodeg penfill ( h.l.medicine ) batch	$221.5K	5
Product:- (alburel 20pct 100ML) human normal albumin solution BP 20% (100ML)	$213.7K	6
Thyronorm 75 MCG 120s pill dose	$206.4K	16
Novomix 30 penfill 5x1 ( h.l.medicine )	$200.0K	4
Airtec sf 250 dpi instacaps 30 s	$180.6K	4
Human normal albumin 20 pct 100ML	$175.0K	4
Influvac tetra 1x0.5ML nh 2023-24 batchno-g47 exp dt-8/24 ( free qty- 700 nos )	$150.0K	3
Ryzodeg penfill h l medicine batch no ps6mv78 exp dt 02	$150.0K	3
Human intravenous immunoglobulin 5 pct	$131.1K	3
Airtec fb 400 instacaps 30 s ( h l	$129.2K	3
Thyronorm 50 MCG 120s pill dose ( h l	$128.7K	13

Pharmachem Private Limited imports 2,584 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rituximab	Advanced Oncology	$179.0K	16	0.9%	12
2	Brufen	Brand Names & OTC Products	$60.7K	21	1.4%	12
3	Adalimumab	Biologics & Immunotherapy	$22.7K	4	1.9%	4
4	Liraglutide	Diabetes & Endocrine	$20.0K	5	0.5%	5

Pharmachem Private Limited imports 4 pharmaceutical products across 4 categories into Nepal totaling $282.4K.

Pharmachem Private Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmachem Private Limited, established in 1988, is a prominent pharmaceutical importer and distributor based in Birgunj, Nepal. As a member of the diversified "KABRA" Group of Companies, Pharmachem operates within a conglomerate engaged in sectors such as banking and finance, automobiles, petrochemicals, LPG production, pharmaceuticals, FMCG marketing, and real estate. The group's investments and assets exceed NPR 10 billion across various parts of Nepal.

Pharmachem's primary role in Nepal's pharmaceutical distribution network is that of an importer and wholesaler. The company sources a wide range of finished pharmaceutical formulations from India, including tablets, capsules, syrups, and injections, to meet the diverse healthcare needs of the Nepali market. This strategic sourcing enables Pharmachem to provide a comprehensive portfolio of pharmaceutical products to its clientele.

2Distribution Network

Pharmachem Private Limited operates its main office in Birgunj, Nepal, and has a branch office in Kathmandu. The Kathmandu office, initially established for regulatory purposes, is slated to expand into full-fledged sales and distribution operations in the near future. This expansion aims to enhance the efficient and reliable distribution of life-saving medications in the capital city.

While specific details about warehouse locations and logistics capabilities are not publicly disclosed, Pharmachem's strategic presence in both Birgunj and Kathmandu suggests a distribution network designed to effectively serve the central and western regions of Nepal. The company's plans to expand its operations in Kathmandu indicate a commitment to strengthening its logistics and distribution infrastructure to meet the growing demand for pharmaceutical products across the country.

3Industry Role

In Nepal's pharmaceutical supply chain, Pharmachem Private Limited functions primarily as an importer and wholesaler. By sourcing a diverse array of finished pharmaceutical formulations from India, the company plays a crucial role in ensuring the availability of essential medications throughout Nepal. This position allows Pharmachem to bridge the gap between international pharmaceutical manufacturers and the Nepali healthcare system, facilitating access to a wide range of therapeutic options for healthcare providers and patients alike.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmachem Private Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Pharmachem Private Limited's sourcing strategy is characterized by a diversified supplier base, with 14 unique Indian suppliers contributing to its total import value of $282,000 USD across 46 shipments. The top five suppliers—Abbott India Limited, USV Private Limited, Glenmark Pharmaceuticals Limited, Reliance Life Sciences Private Limited, and Lupin Limited—collectively account for approximately 87.3% of the total import value. This indicates a strategic choice to maintain strong relationships with key suppliers while mitigating risks associated with over-reliance on a single source.

The shipment data reveals a stable and consistent relationship between Pharmachem and its suppliers. The high number of shipments from these suppliers suggests a well-established and reliable supply chain, which is essential for maintaining the steady availability of pharmaceutical products in the Nepali market. This diversified sourcing approach not only reduces potential supply chain disruptions but also allows Pharmachem to leverage the strengths and specialties of various suppliers to meet the diverse needs of the healthcare sector in Nepal.

2Supply Chain Resilience

Pharmachem Private Limited's supply chain exhibits resilience through its diversified sourcing strategy and established relationships with multiple Indian pharmaceutical manufacturers. The company's import data indicates a consistent flow of shipments from a range of suppliers, suggesting a robust and dependable supply chain capable of adapting to market demands and potential disruptions.

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

In Nepal, the Department of Drug Administration (DDA) serves as the primary regulatory authority overseeing the pharmaceutical sector. The DDA is responsible for the regulation of drugs, including their manufacture, import, export, sale, distribution, and quality control. The legal framework governing pharmaceuticals in Nepal is primarily established by the Drug Act 2035 (1978), which provides comprehensive guidelines for the pharmaceutical industry. Additional regulations, such as the Drug Registration Regulation 2038 (1981) and the Drug Standard Regulation 2043 (1986), further detail the procedures and standards for drug registration and quality assurance.

For Indian pharmaceutical exporters, understanding and complying with these regulations is essential for ensuring the legal importation and sale of their products in Nepal. The DDA's guidelines encompass various aspects, including product registration, quality standards, and labeling requirements, all of which must be met to facilitate the smooth entry of pharmaceutical products into the Nepali market.

2Import Licensing & GMP

Import licensing in Nepal is governed by the Department of Drug Administration (DDA), which requires all pharmaceutical products to be registered before they can be imported and sold. The registration process involves submitting detailed documentation, including product information, manufacturing details, and quality control measures, to ensure compliance with Nepal's regulatory standards.

Pharmachem Private Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Pharmachem Private Limited's product strategy focuses on importing a diverse range of pharmaceutical formulations across various therapeutic categories. The company's top five imported products—Rituximab, Brufen, Adalimumab, Liraglutide, and others—indicate a strategic emphasis on critical therapeutic areas such as oncology, pain management, immunology, and endocrinology. This selection aligns with the growing healthcare needs in Nepal, where there is an increasing demand for advanced treatments in these areas.

The market demand for these products is driven by factors such as an aging population, rising prevalence of chronic diseases, and greater awareness of advanced treatment options among healthcare providers and patients. By focusing on these therapeutic areas, Pharmachem aims to address significant health challenges in Nepal and contribute to improving patient outcomes through access to essential medications.

2Sourcing Profile

Pharmachem Private Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India, a country known for its robust pharmaceutical manufacturing sector. The company's portfolio includes a wide array of products, indicating a preference for sourcing generic drugs that offer cost-effective alternatives to branded medications. This approach allows Pharmachem to provide a comprehensive range of therapeutic options to the Nepali market while maintaining affordability.

India's pharmaceutical

Frequently Asked Questions — Pharmachem Private Limited

What products does Pharmachem Private Limited import from India?

Pharmachem Private Limited imports 4 pharmaceutical products across 4 categories. Top imports: Rituximab ($179.0K), Brufen ($60.7K), Adalimumab ($22.7K), Liraglutide ($20.0K).

Who supplies pharmaceuticals to Pharmachem Private Limited from India?

Pharmachem Private Limited sources from 14 verified Indian suppliers. The primary supplier is Abbott India Limited (30.9% of imports, $11.6M).

What is Pharmachem Private Limited's total pharmaceutical import value?

Pharmachem Private Limited's total pharmaceutical import value from India is $282.4K, based on 46 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmachem Private Limited focus on?

Pharmachem Private Limited imports across 4 categories. The largest: Advanced Oncology (63.4%), Brand Names & OTC Products (21.5%), Biologics & Immunotherapy (8.0%).

Get Full Pharmachem Private Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.